A study to determine the ability of AF-219 to affect the cough reflex in healthy volunteers and in people affected by long-term coughing

Registry ID

EUCTR2015-000464-34

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Afferent Pharmaceuticals, Inc.

Start date

2015-04-29

Completion date

2016-05-19

Last update

2026-08-16

Conditions

• Chronic Cough

Summary

To assess the effect of single doses of 300 mg and 50 mg AF-219 on cough reflex sensitivity to capsaicin in both healthy and chronic cough subjects

Locations

• , , UK

Related clinical trials

• Biomarkers and Respiratory Omics as New CHildren Opportunities - Study of Clinical Outcomes and Predictivity Evaluation
• Remodelling of the Lower Airways in Chronic Cough
• Finnish Children´s Protracted Cough
• Efficacy of Behavioral Therapy for Chronic Refractory Cough
• An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough
• Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients

View on source registry